Evaluation of the drug-drug interaction between Ticagrelor and Venlafaxine when taken together in healthy volunteers

Study identifier:D5130C00073

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A sequential, open label study to compare the pharmacokinetics, safety and tolerability of Ticagrelor and Venlafaxine given concomitantly in healthy subjects aged 18 to 45 years

Medical condition

drug drug interaction

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Ticagrelor, Venlaflaxin

Sex

All

Actual Enrollment

22

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 May 2011
Primary Completion Date: 01 Mar 2012
Study Completion Date: 01 Mar 2012

Study design

Allocation: N/A
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Sept 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria